*Corresponding Author: R Gowri, Associate Professor, Department of Pharmaceutics, Jaya College of Pharmacy, Thiruninravur, India.

Received: January 18, 2022; Published: Macrh 04, 2022

Abstract

Jock itch is a annoying contagious pathogenic fungal infection also known as Tinea cruris mostly occur in groin area, inner thighs and buttocks. Nowadays Jock itch is a widespread pathological infection with substantial history influencing human population. It prevails most common among people with Diabetes mellitus, and also to athletes due to prolonged exposure to moisture. Jock itch usually causes redness, flakiness, peeling r cracking of skin in the groin, thigh and buttocks area. The other causative factors are moisture, irritation and bacterial overgrowth. Jock itch is an infectious disease which spreads by close skin contact or by sharing the clothes and other accessories like shoe socks, scarf or towels. Men are more susceptible to Jock itch particularly obese person due to greater number of folds on the skin where they are likely to contract an infection. An itchy, stinging burning rash forms on infected skin. Usage of Antifungal cream continuously for 2-4 weeks is highly recommended treatment by physicians for Jock itch followed by keeping groin areas clean and avoiding excess moisture. Few people are prone to Jock itch due to maintenance of poor hygiene, possible altered immune status and predisposing skin conditions like eczema. In this review causes, symptoms and its impact on health has been discussed in detail.

Keywords: Antifungal Cream; Eczema; Groin Area; Jock Itch

Bibliography

1. B Gupta AK., et al. “Tinea corporis, Tinea cruris, Tinea nigra, and Piedra”. Dermatologic Clinics3 (2003): 395-400.
2. Ely JW., et al. “Diagnosis and management of tinea infections”. American Family Physician10 (2014): 702-710.
3. El-Gohary M., et al. “Topical antifungal treatments for tinea cruris and tinea corposris”. Cochrane Database System Review 8 (2014): CD009992.
4. Libby Edwards and Peter J Lynch. “Genital Dermatology Atlas”. Lippincott Williams and Wilkins (2010): 67.
5. Hay Roderick J., et al. “32. Fungal Infections". In Griffiths, Christopher; Barker, Jonathan; Bleiker, Tanya O.; Chalmers, Robert; Creamer, Daniel (eds.). Rook's Textbook of Dermatology, 4 Volume Set. John Wiley and Sons (2016): 47.
6. Pires C A A., et al. “Clinical, epidemiological, and therapeutic profile of dermatophytosis”. Anais Brasileiros de Dermatología 2 (2014): 259-264.
7. Ferri FF. “Tinea cruris”. In: Ferri's Clinical Advisor 2020. Elsevier; (2020).
8. Kelly BP. “Superficial fungal infections”. Pediatric Reviews4 (2012): e22-e37.
9. Pariser RJ and Pariser DM. “Primary care physicians' errors in handling cutaneous disorders. A prospective survey”. The Journal of American Academy of Dermatology 17 (1987): 239-245.
10. Durosaro O., et al. “Incidence of cutaneous lupus erythematosus, 1965-2005: a population-based study”. Archives of Dermatological Research3 (2009): 249-253.
11. Andrews MD and Burns M. “Common tinea infections in children”. American Family Physician10 (2008): 1415-1420.
12. Bhat YJ., et al. “Can dermoscopy serve as a diagnostic tool in dermatophytosis? A pilot study”. Indian Dermatology Online Journal5 (2019): 530-535.
13. Sahoo AK and Mahajan R. “Management of tinea corporis, tinea cruris, and tinea pedis: A comprehensive review”. Indian Dermatology Online Journal2 (2016): 77-86.
14. Havlickova B., et al. “Epidemiological trends in skin mycoses worldwide external icon”. Mycoses 51 (2008): 2-15.
15. Schieke SM and Garg A. “Superficial fungal infection”. In LA Goldman et al., eds., Fitzpatrick's Dermatology in General Medicine, 8^th, 2 (2012): 2277-2301.
16. Papadakis MA., et al. “Dermatologic disorders”. In: Current Medical Diagnosis and Treatment 2016. 55^th New York, N.Y.: The McGraw-Hill Companies (2016).
17. Elewski BE., et al. “Fungal diseases”. In: Bolognia JL, Schaffer JV, Cerroni L, eds. Dermatology. 4^th Philadelphia, PA: Elsevier (2018): chap 77.
18. Khanna D., et al. “Luliconazole for the treatment of fungal infections an evidence based review”. Core Evidence 9 (2014): 113-124.
19. Aggarwal N., et al. “Formulation, characterization and evaluation of an optimized microemulsion formulation of griseofulvin for topical application”. Colloids and Surfaces B: Biointerfaces 105 (2013): 158-166.
20. Thompson DA and Jock itch. “Adult Telephone Protocols: Office Version”. 4^th American Academy of Pediatrics (2018).
21. Wilson EK., et al. “Cutaneous infections in wrestlers external icon”. Sports Health 5 (2013): 423-437.
22. Pecci M., et al. “Skin conditions in the athlete external icon”. American Journal of Sports Medicine 37 (2009): 406-418.
23. Nadalo D., et al. “What is the best way to treat tinea cruris?” Journal of Family Practice 55 (2006): 256-258.
24. Weitzman I and Summerbell RC. “The dermatophytes”. Clinical Microbiology Reviews 8 (1995): 240-259.
25. Havlickova B., et al. “Epidemiological trends in skin mycoses worldwide”. Mycoses 51 (2008): 2-15.
26. Safran MR., et al. “Tinea cruris (jock itch)”. In: Safran MR, Zachazewski J, Stone DA, eds. Instructions for Sports Medicine Patients. 2^nd Philadephia, PA: Elsevier (2012).
27. Kaushik N., et al. “Superficial fungal infections”. Prime Care4 (2015): 501-516.

Citation: R Gowri., et al. “Review on Jock Itch". Acta Scientific Clinical Case Reports 3.4 (2022): 21-25.

Copyright: © 2022 R Gowri., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.